Skip to main content
Top
Published in: Neurocritical Care 1/2017

01-09-2017

Emergency Neurological Life Support: Acute Ischemic Stroke

Authors: Hartmut Gross, Noah Grose

Published in: Neurocritical Care | Special Issue 1/2017

Login to get access

Abstract

Acute ischemic stroke is a neurological emergency that can be treated with time-sensitive interventions, including both intravenous thrombolysis and endovascular approaches to thrombus removal. Extensive study has demonstrated that rapid, protocolized, assessment and treatment is essential to improving neurological outcome. For this reason, acute ischemic stroke was chosen as an emergency neurological life support protocol. The protocol focuses on the first hour of medical care following the acute onset of a neurological deficit.
Literature
3.
go back to reference Higashida R, et al. Interactions within stroke systems of care: a policy statment from the American Heart Association/American Stroke Association. Stroke. 2013;44:2961–84.CrossRefPubMed Higashida R, et al. Interactions within stroke systems of care: a policy statment from the American Heart Association/American Stroke Association. Stroke. 2013;44:2961–84.CrossRefPubMed
4.
go back to reference Jauch EC, et al. Guidelines for the Early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.CrossRefPubMed Jauch EC, et al. Guidelines for the Early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.CrossRefPubMed
5.
go back to reference Telestroke guidelines. American Telemedicine Association (pending release as of March 2017). Telestroke guidelines. American Telemedicine Association (pending release as of March 2017).
7.
go back to reference Wechsler LR, et al. Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48:e3–25.CrossRefPubMed Wechsler LR, et al. Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48:e3–25.CrossRefPubMed
8.
go back to reference Thomalla G, et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE_UP). Int J Stroke. 2014;9(6):829–36.CrossRefPubMed Thomalla G, et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE_UP). Int J Stroke. 2014;9(6):829–36.CrossRefPubMed
9.
go back to reference Koga M, et al. Thrombolysis for acute wake-up and unclear-onset strokes with alteplase at 0.6 mg/kg (THAWS) trial. Int J Stroke. 2014;9(8):1117–24.CrossRefPubMedPubMedCentral Koga M, et al. Thrombolysis for acute wake-up and unclear-onset strokes with alteplase at 0.6 mg/kg (THAWS) trial. Int J Stroke. 2014;9(8):1117–24.CrossRefPubMedPubMedCentral
10.
go back to reference Barreto AD, et al. Prospective, open label safety study of intravenous recombinent tissue plasminogen activator in wake-up stroke. Ann Neurol. 2016;80:211–8.CrossRefPubMed Barreto AD, et al. Prospective, open label safety study of intravenous recombinent tissue plasminogen activator in wake-up stroke. Ann Neurol. 2016;80:211–8.CrossRefPubMed
11.
go back to reference Smith EE, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator. Stroke. 2011;42:3110–5.CrossRefPubMed Smith EE, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator. Stroke. 2011;42:3110–5.CrossRefPubMed
12.
go back to reference The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic. Stroke. 1997;28:2109–18.CrossRef The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic. Stroke. 1997;28:2109–18.CrossRef
13.
go back to reference Daemaerschalk BM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. Stroke. 2016;47:581–641.CrossRef Daemaerschalk BM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. Stroke. 2016;47:581–641.CrossRef
14.
go back to reference Hacke W, et al. Thrombolysis with alteplase 3–4.5 h after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.CrossRefPubMed Hacke W, et al. Thrombolysis with alteplase 3–4.5 h after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.CrossRefPubMed
15.
go back to reference Summers D, et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke. 2009;40(8):2911–44.CrossRefPubMed Summers D, et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke. 2009;40(8):2911–44.CrossRefPubMed
16.
17.
go back to reference Furlan A, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003–11.CrossRefPubMed Furlan A, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003–11.CrossRefPubMed
18.
go back to reference Ogawa A, et al. Randomized trial of intraarterial infusion of urokinase within 6 h of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (melt) Japan. Stroke. 2007;38:2633–9.CrossRefPubMed Ogawa A, et al. Randomized trial of intraarterial infusion of urokinase within 6 h of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (melt) Japan. Stroke. 2007;38:2633–9.CrossRefPubMed
19.
go back to reference Berkhemer OA, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [MR CLEAN]. N Engl J Med. 2015;372:11–20.CrossRefPubMed Berkhemer OA, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [MR CLEAN]. N Engl J Med. 2015;372:11–20.CrossRefPubMed
20.
go back to reference Campbell BC, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection [EXTEND-IA]. N Engl J Med. 2015;372:1009–18.CrossRefPubMed Campbell BC, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection [EXTEND-IA]. N Engl J Med. 2015;372:1009–18.CrossRefPubMed
21.
go back to reference Goyal M, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke [ESCAPE]. N Engl J Med. 2015;372:1019–30.CrossRefPubMed Goyal M, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke [ESCAPE]. N Engl J Med. 2015;372:1019–30.CrossRefPubMed
22.
go back to reference Jovin TG, et al. Thrombectomy within 8 h after symptom onset in ischemic stroke [REVASCAT]. N Engl J Med. 2015;372:2296–306.CrossRefPubMed Jovin TG, et al. Thrombectomy within 8 h after symptom onset in ischemic stroke [REVASCAT]. N Engl J Med. 2015;372:2296–306.CrossRefPubMed
23.
go back to reference Saver JL, et al. Stent-retriever thrombectomy after intravenous t-PA versus t-PA alone in stroke [SWIFT PRIME]. N Engl J Med. 2015;372:2285–95.CrossRefPubMed Saver JL, et al. Stent-retriever thrombectomy after intravenous t-PA versus t-PA alone in stroke [SWIFT PRIME]. N Engl J Med. 2015;372:2285–95.CrossRefPubMed
24.
go back to reference Powers WJ, et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. Stroke. 2015;46:3020–35.CrossRefPubMed Powers WJ, et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. Stroke. 2015;46:3020–35.CrossRefPubMed
25.
go back to reference Anderson CS. Presentation at international stroke conference 2017, Houston, Texas. Feb 2017. Anderson CS. Presentation at international stroke conference 2017, Houston, Texas. Feb 2017.
26.
go back to reference Wijdicks E, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling. Stroke. 2014;45:1222–38.CrossRefPubMed Wijdicks E, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling. Stroke. 2014;45:1222–38.CrossRefPubMed
27.
go back to reference Fullerton HJ, et al. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189–94.CrossRefPubMed Fullerton HJ, et al. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189–94.CrossRefPubMed
28.
go back to reference Giroud M, et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48:1343–8.CrossRefPubMed Giroud M, et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48:1343–8.CrossRefPubMed
29.
go back to reference Mallick AA, et al. Childhood arterial ischemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol. 2014;13:35–43.CrossRefPubMed Mallick AA, et al. Childhood arterial ischemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol. 2014;13:35–43.CrossRefPubMed
30.
31.
go back to reference Ichord RN, et al. Interrater reliability of the pediatric national institutes of health stroke scale (PEDNIHSS) in a multicenter study. Stroke. 2011;42:613–7.CrossRefPubMedPubMedCentral Ichord RN, et al. Interrater reliability of the pediatric national institutes of health stroke scale (PEDNIHSS) in a multicenter study. Stroke. 2011;42:613–7.CrossRefPubMedPubMedCentral
33.
go back to reference Adams RJ, et al. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.CrossRefPubMed Adams RJ, et al. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.CrossRefPubMed
34.
go back to reference Easton JD, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40:2276–93.CrossRefPubMed Easton JD, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40:2276–93.CrossRefPubMed
35.
go back to reference Cucchiara B, Ross M. Transient ischemic attack: risk stratification and treatment. Ann Emerg Med. 2008;52:S27–39.CrossRefPubMed Cucchiara B, Ross M. Transient ischemic attack: risk stratification and treatment. Ann Emerg Med. 2008;52:S27–39.CrossRefPubMed
36.
go back to reference Kennedy J, et al. Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961–9.CrossRefPubMed Kennedy J, et al. Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961–9.CrossRefPubMed
37.
go back to reference Stone NJ, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;129:S1–45.CrossRefPubMed Stone NJ, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;129:S1–45.CrossRefPubMed
38.
go back to reference Lip GY, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137:263–72.CrossRefPubMed Lip GY, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137:263–72.CrossRefPubMed
39.
go back to reference Pisters R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093–100.CrossRefPubMed Pisters R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093–100.CrossRefPubMed
40.
go back to reference Bruce N, et al. Medico-legal aspects of using tissue plasminogen activator in acute ischemic stroke. Curr Treat Options Cardiovasc Med. 2011;13:233–9.CrossRefPubMedPubMedCentral Bruce N, et al. Medico-legal aspects of using tissue plasminogen activator in acute ischemic stroke. Curr Treat Options Cardiovasc Med. 2011;13:233–9.CrossRefPubMedPubMedCentral
Metadata
Title
Emergency Neurological Life Support: Acute Ischemic Stroke
Authors
Hartmut Gross
Noah Grose
Publication date
01-09-2017
Publisher
Springer US
Published in
Neurocritical Care / Issue Special Issue 1/2017
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-017-0449-9

Other articles of this Special Issue 1/2017

Neurocritical Care 1/2017 Go to the issue